Page last updated: 2024-10-22

albuterol and Laryngeal Neoplasms

albuterol has been researched along with Laryngeal Neoplasms in 2 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Laryngeal Neoplasms: Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mirza, N1
Kasper Schwartz, S1
Antin-Ozerkis, D1
Walle, T1
Eaton, EA1
Walle, UK1
Pesola, GR1

Other Studies

2 other studies available for albuterol and Laryngeal Neoplasms

ArticleYear
Laryngeal findings in users of combination corticosteroid and bronchodilator therapy.
    The Laryngoscope, 2004, Volume: 114, Issue:9

    Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Albuterol; Andros

2004
Stereoselective metabolism of RS-albuterol in humans.
    Clinical reviews in allergy & immunology, 1996,Spring, Volume: 14, Issue:1

    Topics: Adrenergic beta-Agonists; Albuterol; Biotransformation; Carcinoma; Cells, Cultured; Humans; Laryngea

1996